Affiliation:
1. Current affiliation Liv Hospital
2. Hacettepe University
3. Hacettepe University Hospital
Abstract
Abstract
Background
Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder characterized by distinct clinical features.
Aim
This study aims to address this gap by investigating the demographic and clinical features of NF1 in the Turkish population.
Methods
A retrospective review of the medical records of 128 patients diagnosed with Neurofibromatosis Type 1 (NF1) over a three-year period was conducted.The analysis focused on investigating the demographic and clinical characteristics of the patients, including key parameters such as vitamin D levels and also Body Mass Index (BMI).
Result
Nevus anemicus was present in 32.8% of NF1 patients, and a significant association was found between nevus anemicus and low vitamin D levels (p = 0.001). Although a higher frequency of neurofibromas was observed in patients with low serum vitamin D levels, but the difference was not statistically significant.
Conclusion
Our findings suggest an association between NF1 and lower vitamin D levels. Additionally, individuals with decreased vitamin D levels may demonstrate an increased susceptibility to the development of neurofibromas and a higher prevalence of nevus anemicus. To gain a better understanding of this relationship, we propose the necessity of a prospective study. Such a study would be instrumental in evaluating the correlation between nevus anemicus and vitamin D levels in both NF1 patients and a healthy control group.
Publisher
Research Square Platform LLC
Reference43 articles.
1. Clinical features and pathobiology of neurofibromatosis 1;Korf BR;Journal of child neurology,2002
2. Nutritional, muscular and metabolic characteristics in patients with neurofibromatosis type 1;Koga M;The Journal of dermatology,2016
3. Ferner RE, Huson SM, Evans DGR, Ferner RE (2011). Neurofibromatoses in clinical practice.Springer Science & Business Media, pp: 1–46.
4. Von Recklinghausen neurofibromatosis;Riccardi VM;The New England journal of medicine,1981
5. Neurofibromatosis type 1: a multidisciplinary approach to care;Hirbe AC;The Lancet. Neurology,2014